Subcutaneous Absorption Rate
Also known as: SC absorption · SubQ uptake rate
Subcutaneous absorption rate is how fast a drug injected into the fatty layer under your skin moves into your bloodstream.
After a subcutaneous (SubQ) injection, the drug sits in the fatty tissue under the skin and has to travel through the spaces between cells to reach small blood vessels or lymph vessels. That transport is a major reason SubQ absorption of biologic drugs is relatively slow and often incomplete. Size influences the route: in a sheep study, the share of a dose absorbed through lymph rose with molecular weight, from 4% for a small molecule to 21% for a 5,200 Da molecule and about 60% for a 19,000 Da protein, and molecules above roughly 16,000 Da were absorbed mainly through the lymphatics. A review of biologic drugs describes proteins over 20 kDa as mostly absorbed via lymph.
Absorption rate is usually described by Tmax (time to peak) or an absorption rate constant (ka). Semaglutide, for example, reaches its maximum concentration 1 to 3 days after a SubQ dose. When absorption is slower than elimination, absorption becomes the step that sets the shape of the curve and even the apparent half-life, a situation called flip-flop kinetics.
Why it matters
Absorption rate decides how sharp the peak is and how soon an effect could begin, while bioavailability decides how much arrives in total. Injection site is often blamed for differences, but for semaglutide the label reports similar exposure whether it is injected in the abdomen, thigh or upper arm. The same label instructs using a different injection site each week when injecting in the same body region.
Unless a claim cites a human absorption study for that specific peptide, treat statements like 'the abdomen absorbs fastest' or 'this peptide absorbs within minutes' as guesses for that compound. Data from large proteins and antibodies also do not carry over directly to small peptides, because size changes how a molecule leaves the injection site.
How to read absorption data
- Look for Tmax and the absorption rate constant (ka), plus the route and site used in the study.
- Convert ka to an absorption half-life: 0.693 / ka.
- Compare the absorption half-life with the elimination half-life; if absorption is much slower, the half-life measured after SubQ dosing reflects absorption (flip-flop).
- Check whether the source compared injection sites directly before assuming one site is faster.
Absorption half-life = 0.693 / ka; fraction not yet absorbed after time t = 0.5^(t / absorption half-life) (first-order absorption)
Hypothetical peptide with ka = 0.1 per hour: absorption half-life = 0.693 / 0.1 = 6.93, about 7 hours. After 14 hours (about 2 absorption half-lives), 0.5^2 = 25% has not yet been absorbed; after 28 hours (about 4), 0.5^4 ≈ 6% remains. If its elimination half-life were 1 hour, elimination would outpace absorption, and plasma levels after the peak would fall with a roughly 7-hour half-life, not 1 hour: that is flip-flop.
Common mistakes
- Assuming the abdomen always absorbs fastest; for semaglutide the label reports similar exposure across abdomen, thigh and upper arm.
- Confusing absorption rate (how fast) with bioavailability (how much).
- Reading a long apparent half-life after SubQ dosing as slow elimination when it may be slow absorption.
- Injecting into the exact same spot every time; the semaglutide label instructs rotating sites within a region.
- Applying absorption data from large proteins or antibodies to small peptides.
Sources
- ReviewSubcutaneous absorption of biotherapeutics: knowns and unknowns. Drug Metab Dispos, 2014. PMID 25100673.
- Preclinical studyEffect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. Pharm Res, 1990. PMID 2137911.
- Prescribing informationOZEMPIC (semaglutide) injection, for subcutaneous use: Prescribing Information. Novo Nordisk (FDA-approved labeling), 2026.
Page updated . How we grade evidence: methodology.
Related Terms
Bioavailability
Bioavailability (F) is the fraction of a dose that reaches your bloodstream as intact drug, compared with the same dose given intravenously.
Subcutaneous (SubQ) Injection
A subcutaneous (SubQ) injection delivers a drug into the fat layer between the skin and the muscle, where it is absorbed gradually.
Injection Site Rotation
Injection site rotation means moving each injection to a different spot so the same patch of tissue is not injected repeatedly.
Look up any peptide term inside DoseCraft Pro
The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.
Start Free Trial